US Stock MarketDetailed Quotes

RXRX Recursion Pharmaceuticals

Watchlist
  • 10.050
  • +0.570+6.01%
Close May 14 16:00 ET
  • 10.180
  • +0.130+1.29%
Post 19:59 ET
2.39BMarket Cap-6165P/E (TTM)

Recursion Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Recursion Pharmaceuticals Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 9, 2024

Revenue(YoY)

13.79M

+13.68%
EPS(YoY)

-0.39

-14.71%
Analyst Rating

Buy

May 14, 2024

Recursion Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 13.933M--
--2024/Q2-- / 13.750M--
May 9, 20242024/Q113.794M / 13.067M--
Feb 27, 20242023/Q410.891M / 20.352M--
--2023/Q310.533M / 12.870M--
--2023/Q211.017M / 11.915M--
--2023/Q112.134M / 13.154M--
--2022/Q413.676M / 24.000M--
--2022/Q313.160M / 6.850M--
--2022/Q27.674M / 5.400M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 13.933M--
--2024/Q2-- / 13.750M--
May 9, 20242024/Q113.794M / 13.067M--
Feb 27, 20242023/Q410.891M / 20.352M--
--2023/Q310.533M / 12.870M--
--2023/Q211.017M / 11.915M--
--2023/Q112.134M / 13.154M--
--2022/Q413.676M / 24.000M--
--2022/Q313.160M / 6.850M--
--2022/Q27.674M / 5.400M--

Unlock Free Earnings Estimates

Recursion Pharmaceuticals Earnings Reports

  • Recursion Pharmaceuticals | 10-Q: Quarterly report

    May 10 04:22

  • Recursion Pharmaceuticals | 10-K: Annual report

    Feb 29 21:33

  • Recursion Pharmaceuticals: Q3 2023 Earnings Report

    Nov 9, 2023 21:08

  • Recursion Pharmaceuticals | 10-Q: Q2 2023 Earnings Report

    Aug 8, 2023 20:08

    • Read more

    Analysis

    Analyst Rating

    Updated: May 14, 2024

    Buy

    • Buy

      33.33%

    • Hold

      66.67%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg
    Concept Top Gainers Yesterday
    Top Gainers Yesterday
    Intraday+1.02%